发明名称 |
EGFR AND PAR2 REGULATION OF INTESTINAL PERMEABILITY |
摘要 |
<p>The present invention provides a method of treating an autoimmune disease, comprising the steps of increasing transepithelial electrical resistance leading to decreased cell permeability. Further provided is ajnethod of treating celiac disease in an individual in need of such treatment, comprising the steps of: administering an antibody directed against single chain zonulin thereby inhibiting epidermal growth factor receptor and inhibiting PAR2.</p> |
申请公布号 |
EP2440246(A4) |
申请公布日期 |
2013.08.28 |
申请号 |
EP20100786502 |
申请日期 |
2010.06.10 |
申请人 |
UNIVERSITY OF MARYLAND, BALTIMORE;GOLDBLUM, SIMEON |
发明人 |
FASANO, ALESSIO;LAMMERS, KAREN;SHEA-DONOHUE, TEREZ |
分类号 |
A61K39/395;A61K31/7105;A61P1/04;A61P3/10;A61P37/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|